Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · IEX Real-Time Price · USD
0.564
+0.019 (3.52%)
At close: May 31, 2024, 4:00 PM
0.563
-0.001 (-0.21%)
After-hours: May 31, 2024, 7:09 PM EDT
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $117.12 million as of May 31, 2024. Its market cap has decreased by -52.33% in one year.
Market Cap
117.12M
Enterprise Value
92.60M
1-Year Change
-52.33%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $117.12M, a decrease of -62.71%. That is a compound annual growth rate of -4.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 117.00M | 3.45% |
May 30, 2024 | 113.10M | -5.04% |
May 29, 2024 | 119.10M | -7.60% |
May 28, 2024 | 128.90M | 4.37% |
May 24, 2024 | 123.50M | -3.67% |
May 23, 2024 | 128.20M | -2.88% |
May 22, 2024 | 132.00M | 6.54% |
May 21, 2024 | 123.90M | -2.90% |
May 20, 2024 | 127.60M | -5.41% |
May 17, 2024 | 134.90M | 6.72% |
May 16, 2024 | 126.40M | 4.98% |
May 15, 2024 | 120.40M | 2.12% |
May 14, 2024 | 117.90M | 3.15% |
May 13, 2024 | 114.30M | -1.80% |
May 10, 2024 | 116.40M | 7.28% |
May 9, 2024 | 108.50M | 20.82% |
May 8, 2024 | 89.80M | -7.04% |
May 7, 2024 | 96.60M | 2.66% |
May 6, 2024 | 94.10M | -5.43% |
May 3, 2024 | 99.50M | 6.53% |
May 2, 2024 | 93.40M | -4.01% |
May 1, 2024 | 97.30M | 5.65% |
Apr 30, 2024 | 92.10M | -1.39% |
Apr 29, 2024 | 93.40M | 0.76% |
Apr 26, 2024 | 92.70M | 3.00% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vigil Neuroscience | 119.52M |
Molecular Partners AG | 119.46M |
aTyr Pharma | 119.39M |
FibroGen | 119.37M |
Adicet Bio | 119.15M |
Amylyx Pharmaceuticals | 116.97M |
Seer, Inc. | 116.89M |
Karyopharm Therapeutics | 114.07M |